Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Research We Fund: Extramural Discovery Science
Despite declines in overall cancer mortality in the United States, prostate cancer deaths in Black men represent the greatest mortality disparity in oncology. Black men are 2 to 4 times more likely to die from prostate cancer than any other racial and ethnic group and have a 70% higher incidence rate compared to White men. Unfortunately, less than 5% of participants in oncology clinical trials are Black men. Clinical trials provide an avenue for patients to contribute to research findings for future generations and may offer access to cutting-edge therapies.
The American Cancer Society (ACS) is committed to enhancing racial diversity in clinical trials. To increase participation of Black men with prostate cancer in clinical trials, ACS is announcing a new grant opportunity to support local oncology practices and hospitals in their efforts to expand clinical trial enrollment. This opportunity is part of the ACS IMPACT (Improving Mortality from Prostate Cancer Together) initiative.
Informational Webinar for Applicants: September 16, 2024, 12-1 PM ET
Link to Register for the Webinar
LOI Deadline: September 30, 2024
Application Deadline: November 15, 2024
Anticipated Start Date: April 1, 2025
To support clinical trial recruitment efforts, ACS will facilitate the use of Trial Library, a platform that helps clinical oncology practices identify clinical trials, pre-screen patients, and provides technology-enabled navigation services to ensure patients have needed resources to enroll and complete trials.
To build upon and facilitate the sustainability of efforts to boost diversity in clinical trial enrollment, ACS will connect and involve all awardees with The Prostate Cancer Clinical Trials Consortium (PCCTC). The PCCTC will assist awardees in determining what additional infrastructure and/or training could enhance their site's ability to conduct prostate cancer clinical trials and support the site in obtaining this infrastructure and/or training. Awardees will also have the opportunity to participate in new PCCTC-managed trials.
Questions: Please contact joanne.elena@cancer.org Joanne Elena, PhD, MPH, Scientific Director, Clinical and Cancer Control Research, Extramural Discovery Science